Publications by authors named "Ganapati Bantwal"
Article Synopsis
- - The study analyzed the effectiveness of a quality improvement strategy in managing poorly controlled type 2 diabetes in India and Pakistan, comparing it to standard care over 6.5 years.
- - Participants receiving the quality improvement strategy had better control of multiple diabetes risk factors compared to those receiving usual care, particularly after 2.5 years.
- - The analysis also looked at various health outcomes, including macrovascular and microvascular events, and found notable differences between the two treatment approaches, with some clinics discontinuing the quality improvement strategy during the follow-up period.
Objectives: To assess the cost-effectiveness of a multicomponent strategy versus usual care in people with type 2 diabetes in South Asia.
Design: Economic evaluation from healthcare system and societal perspectives.
Setting: Ten diverse urban clinics in India and Pakistan.
Background: Economic dimensions of implementing quality improvement for diabetes care are understudied worldwide. We describe the economic evaluation protocol within a randomised controlled trial that tested a multi-component quality improvement (QI) strategy for individuals with poorly-controlled type 2 diabetes in South Asia.
Methods/design: This economic evaluation of the Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) randomised trial involved 1146 people with poorly-controlled type 2 diabetes receiving care at 10 diverse diabetes clinics across India and Pakistan.
Background: Achievement of diabetes care goals is suboptimal globally. Diabetes-focused quality improvement (QI) is effective but remains untested in South Asia.
Objective: To compare the effect of a multicomponent QI strategy versus usual care on cardiometabolic profiles in patients with poorly controlled diabetes.
Background: Diabetes is endemic with developing economies contributing to the bulk of this pandemic. Despite the evidence of incremental benefit of glycemic control starting early in life, acceptance of and adherence to modern medications remain suboptimal.
Aims: To determine the hemoglobin A1c (HbA1c)-lowering efficacy and safety of nutritional supplement, PreCrea(®), in adult Indians with newly diagnosed hyperglycemia.